P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Saved in:
Published in | HemaSphere Vol. 6; pp. 280 - 281 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Lippincott Williams & Wilkins
01.06.2022
Wiley |
Online Access | Get full text |
Cover
Loading…
ISSN: | 2572-9241 2572-9241 |
---|---|
DOI: | 10.1097/01.HS9.0000844408.27334.5c |